NEW

Johnson & Johnson to Acquire Shockwave Medical

Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, corresponding to an enterprise value of...

Medline Expands Catheter Portfolio

Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD)....

FDA Clears Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later...

Brainlab, Fujifilm Offer Advanced Neurosurgery Capabilities

FUJIFILM Healthcare Americas Corporation and Brainlab recently announced that Brainlab will be the exclusive U.S. distributor of ARIETTA Precision Ultrasound for neurosurgery applications to be utilized with Brainlab’s surgical navigation systems. ARIETTA Precision,...

RTI Surgical Introduces TETRAfuse 3D Technology

RTI Surgical Inc. has announced the introduction of TETRAfuse 3D Technology.

TETRAfuse 3D Technology is the first 3D printed polymer implant material that has demonstrated trabecular bone ingrowth while maintaining radiolucency and bone-like mechanical properties.

“The 3D printing process creates a nano-rough surface on every aspect of the implant, not just the endplates,” said Robert Watkins IV, M.D. of Marina Spine Center. “This nano-rough surface facilitates bony ingrowth throughout the disc space from endplate to endplate, allowing deeper implant osseointegration.”

TETRAfuse 3D Technology was developed to offer surgeons an interbody material that participates in the fusion process while maintaining bone-like mechanical properties and radiolucent imaging. Bringing these features together combines the osseointegrative advantages of titanium and allograft bone with the benefits surgeons experience with PEEK. RTI will soon announce the release of a family of products manufactured with TETRAfuse 3D Technology, providing a platform that will have many derivative products.

“We are excited about the promise this cutting-edge technology holds for our surgeon customers and their patients,” said Camille Farhat, RTI chief executive officer. “Being the first to offer surgeons a 3D printed interbody polymer optimized to participate in fusion marks another significant milestone for RTI in our quest to continuously deliver relevant and innovative products without compromise.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X